Rezolute, Inc. (RZLT)
4.50
0.00 (0.00%)
USD |
NASDAQ |
Sep 02, 10:41
Rezolute Net Income (TTM) : -81.48M for March 31, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -81.48M |
| December 31, 2025 | -84.23M |
| September 30, 2025 | -77.18M |
| June 30, 2025 | -74.41M |
| March 31, 2025 | -73.00M |
| December 31, 2024 | -71.13M |
| September 30, 2024 | -69.31M |
| June 30, 2024 | -68.46M |
| March 31, 2024 | -58.21M |
| December 31, 2023 | -56.83M |
| September 30, 2023 | -56.48M |
| June 30, 2023 | -51.79M |
| March 31, 2023 | -48.48M |
| December 31, 2022 | -44.02M |
| September 30, 2022 | -43.06M |
| June 30, 2022 | -41.06M |
| March 31, 2022 | -38.13M |
| December 31, 2021 | -30.61M |
| September 30, 2021 | -25.12M |
| June 30, 2021 | -20.90M |
| March 31, 2021 | -17.96M |
| December 31, 2020 | -19.30M |
| September 30, 2020 | -18.87M |
| June 30, 2020 | -20.33M |
| March 31, 2020 | -19.93M |
| Date | Value |
|---|---|
| December 31, 2019 | -34.67M |
| September 30, 2019 | -32.16M |
| June 30, 2019 | -30.45M |
| March 31, 2019 | -39.79M |
| December 31, 2018 | -24.99M |
| September 30, 2018 | -26.54M |
| June 30, 2018 | -29.86M |
| March 31, 2018 | -23.56M |
| December 31, 2017 | -23.98M |
| September 30, 2017 | -23.15M |
| June 30, 2017 | -20.28M |
| March 31, 2017 | -17.96M |
| December 31, 2016 | -16.35M |
| September 30, 2016 | -15.52M |
| June 30, 2016 | -15.00M |
| March 31, 2016 | -14.17M |
| December 31, 2015 | -13.57M |
| September 30, 2015 | -12.44M |
| June 30, 2015 | -11.36M |
| March 31, 2015 | -10.33M |
| December 31, 2014 | -12.24M |
| September 30, 2014 | -11.13M |
| June 30, 2014 | -9.730M |
| March 31, 2014 | -8.755M |
| December 31, 2013 | -8.202M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| SELLAS Life Sciences Group, Inc. | -32.46M |
| AbbVie, Inc. | 6.274B |
| Marker Therapeutics, Inc. | -8.707M |
| Avalo Therapeutics, Inc. | -100.33M |
| Krystal Biotech, Inc. | 241.46M |